HTGM logo

HTGM Shareholders Equity

HTGM Annual Shareholders Equity

$5.39 M
-$5.01 M-48.16%

31 December 2022

HTGM Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HTGM Quarterly Shareholders Equity

$474.50 K
-$4.92 M-91.20%

31 March 2023

HTGM Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HTGM Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.2%-95.8%
3 y3 years-77.5%-97.8%
5 y5 years+276.2%-98.5%

HTGM Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-77.5%-98.5%

HTG Molecular Diagnostics Shareholders Equity History

DateAnnualQuarterly
Mar 2023
-
$474.50 K(-91.2%)
Dec 2022
$5.39 M(-48.2%)
$5.39 M(+346.2%)
Sept 2022
-
$1.21 M(-78.3%)
June 2022
-
$5.57 M(-50.6%)
Mar 2022
-
$11.27 M(+8.4%)
Dec 2021
$10.40 M(-28.2%)
$10.40 M(-30.1%)
Sept 2021
-
$14.89 M(-19.3%)
June 2021
-
$18.44 M(+9.5%)
Mar 2021
-
$16.84 M(+16.3%)
Dec 2020
$14.48 M(-39.6%)
$14.48 M(-10.6%)
Sept 2020
-
$16.20 M(-13.3%)
June 2020
-
$18.68 M(-14.7%)
Mar 2020
-
$21.91 M(-8.6%)
Dec 2019
$23.97 M(+13.6%)
$23.97 M(-14.7%)
Sept 2019
-
$28.12 M(+140.9%)
June 2019
-
$11.67 M(-27.2%)
Mar 2019
-
$16.03 M(-24.0%)
Dec 2018
$21.09 M
$21.09 M(-7.5%)
DateAnnualQuarterly
Sept 2018
-
$22.79 M(-16.3%)
June 2018
-
$27.21 M(-12.1%)
Mar 2018
-
$30.97 M(-1112.2%)
Dec 2017
-$3.06 M(-45.3%)
-$3.06 M(-32.3%)
Sept 2017
-
-$4.52 M(+191.8%)
June 2017
-
-$1.55 M(-85.9%)
Mar 2017
-
-$10.96 M(+96.0%)
Dec 2016
-$5.59 M(-133.1%)
-$5.59 M(+152.5%)
Sept 2016
-
-$2.21 M(-155.1%)
June 2016
-
$4.02 M(-62.0%)
Mar 2016
-
$10.56 M(-37.5%)
Dec 2015
$16.89 M(-170.3%)
$16.89 M(-24.7%)
Sept 2015
-
$22.44 M(-18.4%)
June 2015
-
$27.49 M(-198.0%)
Mar 2015
-
-$28.04 M(+16.6%)
Dec 2014
-$24.04 M(+7.1%)
-$24.04 M(-2.3%)
Sept 2014
-
-$24.60 M(+9.6%)
Dec 2013
-$22.45 M(+22.9%)
-$22.45 M
Dec 2012
-$18.26 M
-

FAQ

  • What is HTG Molecular Diagnostics annual stockholders equity?
  • What is the all time high annual shareholders equity for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics annual shareholders equity year-on-year change?
  • What is HTG Molecular Diagnostics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics quarterly shareholders equity year-on-year change?

What is HTG Molecular Diagnostics annual stockholders equity?

The current annual shareholders equity of HTGM is $5.39 M

What is the all time high annual shareholders equity for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high annual stockholders equity is $23.97 M

What is HTG Molecular Diagnostics annual shareholders equity year-on-year change?

Over the past year, HTGM annual stockholders equity has changed by -$5.01 M (-48.16%)

What is HTG Molecular Diagnostics quarterly stockholders equity?

The current quarterly shareholders equity of HTGM is $474.50 K

What is the all time high quarterly shareholders equity for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high quarterly stockholders equity is $30.97 M

What is HTG Molecular Diagnostics quarterly shareholders equity year-on-year change?

Over the past year, HTGM quarterly stockholders equity has changed by -$10.79 M (-95.79%)